مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: adult, antibody mediated rejection/dt [Drug Therapy], anticoagulant therapy, arteriovenous fistula/pc [Prevention], article, bleeding/si [Side Effect], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/pc [Prevention], deep vein thrombosis/si [Side Effect], Doppler echography, drug dose increase, drug infusion, drug megadose, female, fluid overload/si [Side Effect], graft recipient, heart infarction/pc [Prevention], human, hydration, kidney graft rejection/co [Complication], kidney graft rejection/dt [Drug Therapy], kidney graft rejection/pc [Prevention], kidney transplantation, leg thrombosis/dt [Drug Therapy], leg thrombosis/pc [Prevention], leg thrombosis/si [Side Effect], major clinical study, male, medical record review, non ST segment elevation myocardial infarction/dt [Drug Therapy], non ST segment elevation myocardial infarction/pc [Prevention], non ST segment elevation myocardial infarction/si [Side Effect], priority journal, renal artery thrombosis/dt [Drug Therapy], renal artery thrombosis/pc [Prevention], renal artery thrombosis/si [Side Effect], enoxaparin/sc [Subcutaneous Drug Administration], immunoglobulin G/ae [Adverse Drug Reaction], immunoglobulin G/do [Drug Dose], immunoglobulin G/dt [Drug Therapy], immunoglobulin G/iv [Intravenous Drug Administration], infusion fluid, prednisolone/dt [Drug Therapy], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], antibody mediated rejection/co [Complication], antibody mediated rejection/pc [Prevention], clinical protocol, retrospective study, sex difference, side effect/si [Side Effect], thrombosis prevention, treatment duration, vein thrombosis/dt [Drug Therapy], vein thrombosis/pc [Prevention], vein thrombosis/si [Side Effect], acetylsalicylic acid/ae [Adverse Drug Reaction], acetylsalicylic acid/dt [Drug Therapy], acetylsalicylic acid/iv [Intravenous Drug Administration], clopidogrel/ae [Adverse Drug Reaction], clopidogrel/dt [Drug Therapy], enoxaparin/ae [Adverse Drug Reaction], enoxaparin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30263Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: adult, antibody mediated rejection/dt [Drug Therapy], anticoagulant therapy, arteriovenous fistula/pc [Prevention], article, bleeding/si [Side Effect], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/pc [Prevention], deep vein thrombosis/si [Side Effect], Doppler echography, drug dose increase, drug infusion, drug megadose, female, fluid overload/si [Side Effect], graft recipient, heart infarction/pc [Prevention], human, hydration, kidney graft rejection/co [Complication], kidney graft rejection/dt [Drug Therapy], kidney graft rejection/pc [Prevention], kidney transplantation, leg thrombosis/dt [Drug Therapy], leg thrombosis/pc [Prevention], leg thrombosis/si [Side Effect], major clinical study, male, medical record review, non ST segment elevation myocardial infarction/dt [Drug Therapy], non ST segment elevation myocardial infarction/pc [Prevention], non ST segment elevation myocardial infarction/si [Side Effect], priority journal, renal artery thrombosis/dt [Drug Therapy], renal artery thrombosis/pc [Prevention], renal artery thrombosis/si [Side Effect], enoxaparin/sc [Subcutaneous Drug Administration], immunoglobulin G/ae [Adverse Drug Reaction], immunoglobulin G/do [Drug Dose], immunoglobulin G/dt [Drug Therapy], immunoglobulin G/iv [Intravenous Drug Administration], infusion fluid, prednisolone/dt [Drug Therapy], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], antibody mediated rejection/co [Complication], antibody mediated rejection/pc [Prevention], clinical protocol, retrospective study, sex difference, side effect/si [Side Effect], thrombosis prevention, treatment duration, vein thrombosis/dt [Drug Therapy], vein thrombosis/pc [Prevention], vein thrombosis/si [Side Effect], acetylsalicylic acid/ae [Adverse Drug Reaction], acetylsalicylic acid/dt [Drug Therapy], acetylsalicylic acid/iv [Intravenous Drug Administration], clopidogrel/ae [Adverse Drug Reaction], clopidogrel/dt [Drug Therapy], enoxaparin/ae [Adverse Drug Reaction], enoxaparin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30263Test
LibKey Link